Respiratory syncytial virus G-protein deletion mutants replicate effectively in vitro but have not been detected in nature. Subtyping of RSV strains in hospitalized children in South Africa identified G-protein PCR amplicons significantly reduced in size in 2 out of 209 clinical specimens screened over 4 years. Sequence analysis revealed subtype B strains lacking
nearly the entire G protein ecto-domain in one HIV positive and one HIV exposed child hospitalized with pneumonia. The association of clinical strains lacking most of the G-protein with lower respiratory tract infection in immunocompromised children may have implications for RSV vaccine development.
Respiratory Syncytial Virus (RSV), a Pneumovirus, family Paramyxoviridae, is a major cause of pneumonia in children. Two antigenic subgroups (A and B) exist with partial cross protection(2). Neutralizing antibodies are directed against the F and G surface glycoproteins.
Major antigenic differences are features of the G protein, a type II transmembrane glycoprotein that mediates viral attachment. The G-protein has an ectodomain consisting of a central region of four conserved cysteines, a putative receptor binding site, flanked by two hypervariable regions (6) . Several G-protein genotypes have been documented within each subgroup based predominantly on the second hypervariable region (13, 21, 24) .
Evolutionary studies of subgroup B strains have described major differences in G-protein length due to alternative termination codon usage, premature stop codons, inframe duplications, deletions and insertions (11, 22) . G-proteins of especially subtype B isolates have been identified that are truncated by 30 base pairs due to frame shift mutations (12) . The central region remained conserved in all sequences with an absolute conserved region between amino acid positions 164-187 (26) .
Cell surface glycosaminoglycans (GAGs) are responsible for the majority of RSV attachment to cultured cells leading to infection (4) . RSV virions containing the F-protein as sole surface protein bind to GAGs as well as another unidentified molecule suggesting the F-protein may have an auxiliary role as an attachment protein (16) .
Variation in neutralizing epitopes in the hypervariable region of the G-protein suggest immune selection of new variants may contribute to generation of HRSV diversity (20) . A coldpassaged subtype B mutant containing large deletions spanning most of the coding sequences of the small hydrophobic (SH) and attachment (G) proteins was generated in-vitro.
This virus replicated efficiently in Vero cells, but was found to be overattenuated in RSV seronegative infants and children (7) . Deletion of the central conserved domain and cysteine noose was shown not to affect virus growth in vitro or in vivo (in mice) (17) , although no record exists of strains that lack this in humans with clinical disease. Augmentation of the Th2 immune response by the G-protein as well as antigentic variation in G makes delta G mutants attractive vaccine candidates (18) . A and B by size (10, 23, 24) . Positive specimens resulted in PCR fragments of 950bp for RSV subtype A and 1200bp for subtype B strains in the first round and 700 and 950bp respectively for the nested PCR corresponding with the RSV prototype strain A2 and B1. Figure 1 indicates a diagram of the different primers used.
Two clinical specimens were identified with amplicons that were significantly reduced in size in comparison to the prototype controls. Sequence analysis identified G-protein deletion mutant subtype B strains that lacked most of the ectodomain, including the conserved cysteine noose. These deletion mutant strains as well as one representative strain of each subtype B genotype were selected for full length G-protein sequencing. Furthermore, any specimens that had G-protein subtyping amplicons smaller than the expected size were selected for sequencing as well as a truncated strain previously identified in South Africa
AgJ15_99 (23) . The full length G-protein was amplified with primers: G1-21 (22) and F164
(figure1) with the Titan one-step RT-PCR system (Roche diagnostics, Mannheim, Germany)
according to the manufacturer's recommendations with the following cycle: 50ºC for 30min, 94ºC for 2min, (94ºC for 10sec, 53ºC for 30sec, 68ºC for 1min) X35 cycles, 68ºC for 7min.
This was followed by nested PCR with primers: G32B(15) and F1(14) as described before (23) . PCR products were analyzed on a 1.5% agarose gel, against a 100-bp molecular weight marker (Roche Diagnostics, Mannheim Germany).
Nucleotide sequencing was carried out using the BigDye version 3.0 Kit on an ABI 3130 sequencer (Applied Biosystems, Foster city, CA) using primers G32B; G604B SA367859Pt06 was negative for other viruses detected by the IFA but insufficient material was available for additional PCRs. Attempts to culture virus from these specimens was not successful, probably due to low concentrations present and repeat freeze thawing of specimens that had been screened retrospectively.
These findings suggest that despite being attenuated in immunocompetent children, the G- 
